Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes-Reference-Cited by-同舟云学术

Addressing Administrative and Regulatory Burden in Cancer Clinical Trials: Summary of a Stakeholder Survey and Workshop Hosted by the American Society of Clinical Oncology and the Association of American Cancer Institutes

Published:2016-11-01 Issue:31 Volume:34 Page:3796-3802
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Vose Julie M.¹,Levit Laura A.¹,Hurley Patricia¹,Lee Carrie¹,Thompson Michael A.¹,Stewart Teresa¹,Hofacker Janie¹,Bruinooge Suanna S.¹,Hayes Daniel F.¹

Affiliation:

1. Julie M. Vose, University of Nebraska, Omaha, NE; Laura A. Levit, Patricia Hurley, and Suanna S. Bruinooge, American Society of Clinical Oncology, Alexandria, VA; Carrie Lee, University of North Carolina at Chapel Hill, Chapel Hill, NC; Michael A. Thompson, Aurora Health Care, Milwaukee, WI; Teresa Stewart, New Mexico Cancer Care Alliance, Albuquerque, NM; Janie Hofacker, Association of American Cancer Institutes, Pittsburgh, PA; and Daniel F. Hayes, University of Michigan, Ann Arbor, MI.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.69.6781

Reference3 articles.

1. Challenges With Research Contract Negotiations in Community-Based Cancer Research

2. The Majority of Expedited Investigational New Drug Safety Reports Are Uninformative

3. Strategies to optimize expedited investigational new drug safety reports

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival benefit in EGFR-wild and ALK negative NSCLC patients who participate in clinical trials compared to standard-of-care: Propensity-matched analysis;Lung Cancer;2024-04

2. The Targeted Agent and Profiling Utilization Registry Study: A pragmatic clinical trial;Clinical Trials;2023-07-25

3. A framework for assessing clinical trial site readiness;Journal of Clinical and Translational Science;2023

4. New trends in clinical trials—between complexity and the need for renewal;AboutOpen;2022-06-21

5. Improving the Approach to Defining, Classifying, Reporting and Monitoring Adverse Events in Seriously Ill Older Adults: Recommendations from a Multi-stakeholder Convening;Journal of General Internal Medicine;2022-05-17